US Patent 10946068 IL-2 muteins and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Pandion Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109460680

Patent Inventor Names

Kevin Lewis Otipoby0

Nathan Higginson-Scott0

Joanne L. Viney0

Jyothsna Visweswaraiah0

Erik Robert Sampson0

Date of Patent

March 16, 2021

Patent Application Number

162030180

Date Filed

November 28, 2018

Patent Citations

‌

US Patent 10137206 Nucleic acid products and methods of administration thereof

‌

US Patent 10138298 Anti-IL-2 antibodies and compositions and uses thereof

‌

US Patent 10150802 Superagonists, partial agonists and antagonists of interleukin-2

‌

US Patent 10035836 Modified IL-2 variants that selectively activate regulatory T cells

‌

US Patent 10086046 Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells

‌

US Patent 10093711 Interleukin-2 muteins for the expansion of T-regulatory cells

‌

US Patent 10130659 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

‌

US Patent 10323077 Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

...

Patent Citations Received

‌

US Patent 12084484 Interleukin-2 agents and uses thereof

‌

US Patent 12091440 IL2 and peptide-MHC complex fusion proteins and methods of use thereof

Patent Primary Examiner

‌

Prema M Mertz

Patent abstract

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10946068 IL-2 muteins and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10946068 IL-2 muteins and uses thereof